Pelvic and Extragenital Endometriosis: A Review of the Surgical Management of Deeply Infiltrating Lesions

Erica C. Dun, Friedrich Wieser, Ceana Nezhat
In: Journal of Gynecologic Surgery · 2013 · vol. 29(3) , pp. 118–127 · doi:10.1089/gyn.2012.0119 · W2048719332
review OA: closed CC0
View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This review discusses the surgical management of deeply infiltrating endometriosis in the pelvis, urogenital tract, bowel, diaphragm, and chest for symptom alleviation and fertility improvement.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is a common and chronic inflammatory disorder affecting 10%–16% of women of reproductive age. Although endometriosis is a benign condition, it has negative effects on the quality of life and fertility of women affected. The annual cost in the United States from endometriosis is estimated at $65 billion, because of lost productivity and medical expenses. The socioeconomic impact of endometriosis is evident; however, effective treatment options elude clinicians. Medical management typically consists of nonsteroidal anti-inflammatory drugs and hormonal drugs that suppress ovarian function. Often, however, medical treatment regimens do not satisfactorily alleviate the intractable pelvic pain and are counterproductive for fertility. When medical treatment is suboptimal for managing endometriosis-related symptoms, complete excision of the deeply infiltrating lesions, endometriomas, and associated scar tissue can significantly alleviate pain and improve fertility. In this review, the current management of deeply infiltrating endometriosis, focusing on the surgical treatment of deeply infiltrating disease in the pelvis, urogenital tract, bowel, diaphragm, and chest, are discussed. (J GYNECOL SURG 29:118)

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK